ARCHIVES

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005